We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 16, 2022

Association of the Use of Novel Antihyperglycaemic Drugs With Prevention of COPD Exacerbations Among Patients With Type 2 Diabetes

BMJ : British Medical Journal

 

Additional Info

BMJ : British Medical Journal
Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
BMJ 2022 Nov 01;379(xx)e071380, R Pradhan, S Lu, H Yin, OHY Yu, P Ernst, S Suissa, L Azoulay

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading